168 related articles for article (PubMed ID: 27150145)
21. Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects.
Skrede S; Martins L; Berge RK; Steen VM; López M; Fernø J
Int J Neuropsychopharmacol; 2014 Jan; 17(1):91-104. PubMed ID: 23919889
[TBL] [Abstract][Full Text] [Related]
22. Increase in plasma glucose concentration after intracerebroventricular injection of N,O'-dibutyryl cyclic adenosine 3',5'-monophosphate.
Iguchi A; Gotoh M; Matsunaga H; Ohuchi M; Nomura T; Sakamoto N
Endocrinology; 1986 Jul; 119(1):125-9. PubMed ID: 2873022
[TBL] [Abstract][Full Text] [Related]
23. Effect of cimetidine on pentamidine induced hyperglycemia in rats.
Arino T; Karakawa S; Ishiwata Y; Nagata M; Yasuhara M
Eur J Pharmacol; 2012 Oct; 693(1-3):72-9. PubMed ID: 22968103
[TBL] [Abstract][Full Text] [Related]
24. Prevention of the adverse effects of olanzapine on lipid metabolism with the antiepileptic zonisamide.
Stefanidis A; Watt MJ; Cowley MA; Oldfield BJ
Neuropharmacology; 2017 Sep; 123():55-66. PubMed ID: 28400260
[TBL] [Abstract][Full Text] [Related]
25. Olanzapine effects on body composition, food preference, glucose metabolism and insulin sensitivity in the rat.
Smith GC; Vickers MH; Shepherd PR
Arch Physiol Biochem; 2011 Oct; 117(4):241-9. PubMed ID: 21671852
[TBL] [Abstract][Full Text] [Related]
26. Prostaglandins affect the central nervous system to produce hyperglycemia in rats.
Yatomi A; Iguchi A; Yanagisawa S; Matsunaga H; Niki I; Sakamoto N
Endocrinology; 1987 Jul; 121(1):36-41. PubMed ID: 3474143
[TBL] [Abstract][Full Text] [Related]
27. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063.
Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A
Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111
[TBL] [Abstract][Full Text] [Related]
28. Effects of gatifloxacin on serum glucose concentration in normal and diabetic rats.
Ishiwata Y; Sanada Y; Yasuhara M
Biol Pharm Bull; 2006 Mar; 29(3):527-31. PubMed ID: 16508159
[TBL] [Abstract][Full Text] [Related]
29. Female mice are protected against acute olanzapine-induced hyperglycemia.
Medak KD; Townsend LK; Hahn MK; Wright DC
Psychoneuroendocrinology; 2019 Dec; 110():104413. PubMed ID: 31499390
[TBL] [Abstract][Full Text] [Related]
30. Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents.
Albaugh VL; Henry CR; Bello NT; Hajnal A; Lynch SL; Halle B; Lynch CJ
Obesity (Silver Spring); 2006 Jan; 14(1):36-51. PubMed ID: 16493121
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine induces glucose intolerance through the activation of AMPK in the mouse hypothalamus.
Ikegami M; Ikeda H; Ishikawa Y; Ohsawa M; Ohashi T; Kai M; Kamei A; Kamei J
Eur J Pharmacol; 2013 Oct; 718(1-3):376-82. PubMed ID: 23973646
[TBL] [Abstract][Full Text] [Related]
32. A model of controlled acute hyperglycemia in rats: Effects of insulin and glucagon-like peptide-1 analog.
Saha JK; Xia J; Engle SK; Chen YF; Glaesner W; Jakubowski JA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1159-64. PubMed ID: 16280413
[TBL] [Abstract][Full Text] [Related]
33. Central administration of an orexin receptor 1 antagonist prevents the stimulatory effect of Olanzapine on endogenous glucose production.
Girault EM; Foppen E; Ackermans MT; Fliers E; Kalsbeek A
Brain Res; 2013 Aug; 1527():238-45. PubMed ID: 23830851
[TBL] [Abstract][Full Text] [Related]
34. Olanzapine-induced weight gain: chronic infusion using osmotic minipumps does not result in stable plasma levels due to degradation of olanzapine in solution.
van der Zwaal EM; Luijendijk MC; Adan RA; la Fleur SE
Eur J Pharmacol; 2008 May; 585(1):130-6. PubMed ID: 18378227
[TBL] [Abstract][Full Text] [Related]
35. Synergistic interactions of physiologic increments of glucagon, epinephrine, and cortisol in the dog: a model for stress-induced hyperglycemia.
Eigler N; Saccà L; Sherwin RS
J Clin Invest; 1979 Jan; 63(1):114-23. PubMed ID: 762240
[TBL] [Abstract][Full Text] [Related]
36. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
Bhatt P; Makwana D; Santani D; Goyal R
Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
[TBL] [Abstract][Full Text] [Related]
37. Olanzapine increases hepatic glucose production through the activation of hypothalamic adenosine 5'-monophosphate-activated protein kinase.
Ikegami M; Ikeda H; Ohashi T; Ohsawa M; Ishikawa Y; Kai M; Kamei A; Kamei J
Diabetes Obes Metab; 2013 Dec; 15(12):1128-35. PubMed ID: 23782571
[TBL] [Abstract][Full Text] [Related]
38. Central effects of thyronamines on glucose metabolism in rats.
Klieverik LP; Foppen E; Ackermans MT; Serlie MJ; Sauerwein HP; Scanlan TS; Grandy DK; Fliers E; Kalsbeek A
J Endocrinol; 2009 Jun; 201(3):377-86. PubMed ID: 19273499
[TBL] [Abstract][Full Text] [Related]
39. Modulation of arginine-induced glucagon release by epinephrine and glucose levels in man.
Beard JC; Weinberg C; Pfeifer MA; Best JD; Halter JB; Porte D
J Clin Endocrinol Metab; 1983 Jun; 56(6):1271-7. PubMed ID: 6841561
[TBL] [Abstract][Full Text] [Related]
40. Glucoregulatory hormones in the immobilization stress-induced increase of plasma glucose in fasted and fed rats.
Yamada F; Inoue S; Saitoh T; Tanaka K; Satoh S; Takamura Y
Endocrinology; 1993 May; 132(5):2199-205. PubMed ID: 8477665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
